Betamethasone.pdf - ACTIVE LEARNING TEMPLATE Medication Jen Forbes STUDENT NAME Bethamethasone MEDICATION REVIEW MODULE CHAPTER CATEGORY

Betamethasone.pdf - ACTIVE LEARNING TEMPLATE Medication Jen...

This preview shows page 1 out of 1 page.

Unformatted text preview: ACTIVE LEARNING TEMPLATE: Medication Jen Forbes STUDENT NAME______________________________________ Bethamethasone MEDICATION___________________________________________________________________________ REVIEW MODULE CHAPTER____________ CATEGORY CLASS__antiinflammatories/corticosteroids _____________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Suppresses inflammation and the normal immune response. Therapeutic Use Short-term administration to high-risk mothers before delivery to prevent respiratory distress syndrome in the newborn. Suppression of inflammation and modification of the normal immune response. Replacement therapy in adrenal insufficiency. Complications depression, euphoria, headache,increase intracranial pressure, personality changes, psychoses, restlessness.cataracts, increase intraocular pressure.hypertension.PEPTIC ULCERATION, anorexia, nausea, vomiting. acne, wound healing, ecchymoses, fragility, hirsutism, petechiae.adrenal suppression, hyperglycemia. fluid retention, hypokalemia, hypokalemic alkalosis. THROMBOEMBOLISM, thrombophlebitis. weight gain, weight loss, muscle wasting, osteoporosis,avascular necrosis of joints, muscle pain, cushingoid appearance, increase susceptibility to infection. Medication Administration IM (Adults):0.5–9 mg/day as betamethasone sodium phosphate/acetate suspen-sion in 1–2 divided doses.Prevention of respiratory distress syndrome in new-born —12 mg daily for 2–3 days before delivery Contraindications/Precautions contraindicated in Active untreated infections, Traumatic brain injury, Lactation:Avoid chronic use; Some products contain bisulfites and should be avoided in patients with known hypersensitivity. Use Cautiously in:Chronic treatment; Hypothyroidism; Cirrhosis; Ulcerative colitis; Stress; Potential infections. OB:Safety not established; Pedi:Chronic use will result indecrease growth; use lowest possible dose for shortest period of time. Interactions Additive hypokalemia with thiazide and loop diuretics,oramphotericin B. Hypokalemia may increase risk of digitalis glycoside toxicity. May increase requirement for insulins or oral hypoglycemic agents. Phenytoin, phenobarbital, and rifampin stimulate metabolism; may decrease effectiveness. At chronic doses that suppress adrenal function, may decrease antibody response to and increase riskof adverse reactions from live virus vaccines Evaluation of Medication Effectiveness Decrease in presenting symptoms with minimal systemic side effects. Suppression of the inflammatory and immune responses in autoimmune disorders, allergic reactions, and neoplasms.●Management of symptoms in adrenal insufficiency ACTIVE LEARNING TEMPLATES Nursing Interventions Assess patient for signs of adrenal insufficiency (hypotension, weight loss, weakness, nausea, vomiting, anorexia, lethargy, confusion, restlessness) before and periodically during therapy. Monitor intake and output ratios and daily weights. Observe patient for peripheral edema, steady weight gain, rales/crackles, or dyspnea. Notify health care professional if these occur. Lab Test Considerations:Monitor serum electrolytes and glucose. May cause hyperglycemia, especially in persons with diabetes. May cause hypokalemia. Patients on prolonged courses of therapy should routinely have hematologic values,serum electrolytes, and serum glucose evaluated. May decreas WBC counts. Mayp decrease serum potassium and calcium and increase serum sodium concentrations. Promptly report presence of guaiac-positive stools. Client Education Stopping the medication suddenly may result in adrenal insufficiency(anorexia, nausea, weakness, fatigue, dyspnea, hypotension, hypoglycemia). If these signs appear, notify health care professional immediately. This can be life-threatening. Instruct patient to inform health care pro-fessional promptly if severe abdominal pain or tarry stools occur Therapeutic Procedure  A7 ...
View Full Document

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture